image credit: Adobe Stock

Regeneron turns to IT to accelerate drug discovery

November 4, 2022

Via: CIO

For pharmaceutical companies in the digital era, intense pressure to achieve medical miracles falls as much on the shoulders of CIOs as on lead scientists.

Rigid requirements to ensure the accuracy of data and veracity of scientific formulas as well as machine learning algorithms and data tools are common in modern laboratories.

When Bob McCowan was promoted to CIO at Regeneron Pharmaceuticals in 2018, he had previously run the data center infrastructure for the $81.5 billion company’s scientific, commercial, and manufacturing businesses since joining the company in 2014.

Read More on CIO